3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycythemia Vera
4
Leukemia, Myeloid, Acute
4
Treatment-Refractory Solid Tumors
2
Meningioma
2
Squamous Cell Carcinoma of Head and Neck
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Head and Neck Neoplasms
1
Bone Marrow Neoplasms
1
Bites and Stings
1
Interventions
Cisplatin
5
pembrolizumab
4
Surveys and Questionnaires
2
Radiotherapy
2
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
2
Fluorouracil
2
Docetaxel
2
Cetuximab
2
niraparib
1
monalizumab
1
durvalumab
1
dostarlimab
1
Tablets
1
Surgical Flaps
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
LY2940680
1
Interviews as Topic
1
Combined Modality Therapy
1
Chemical Fractionation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Diseases
×
Hydroxyurea
×
1 year
×
Clear all
No trials found.